Browsing Tag
Philadelphia
44 posts
Why Future Standard handed its $94bn platform to former BlackRock executive Edwin Conway
Future Standard has appointed former BlackRock and Blackstone executive Edwin Conway as chief executive officer, while co-founder Michael Forman becomes full-time executive chairman. The transition gives Conway responsibility for converting the alternative asset manager’s acquisitions, new funds and international expansion into a more integrated global platform.
US heat wave puts 185 million under alerts as July 4 events are cancelled
A dangerous US heat wave has put 185 million people under alerts, cancelled July 4 events and strained power grids across major cities.
FIFA World Cup 2026 host cities explained: How US, Canada and Mexico will stage 104 matches
World Cup 2026 is a city operations test. Sixteen host markets must move fans, manage crowds and turn football into tourism value.
Indian national Anshul Kuncha shot dead in Philadelphia after pizza delivery to vacant apartment
A pizza order led Anshul Kuncha to a vacant unit. His killing now raises hard questions on delivery safety and immigrant worker risk.
AVCT entry at 86p is a bet on AVA6103: What Avacta Group investors should know
Avacta Group sets up a binary AVA6103 readout for late H2 2026. Here is what AVCT retail investors need to weigh before the data lands and runway runs.
Avacta FY25 puts AVCT on a clock: £16.9m cash, two Phase 1 reads, one shot
Avacta Group posts FY25 results with two clinical assets in trial, £16.9m cash, and AVA6103 data due in H2 2026 as AVCT trades near 52-week high.
Avacta Group (AIM: AVCT) delivers preCISION payload data that challenges Enhertu and Datroway tumor selectivity at Science Day 2026
Avacta is no longer pitching a platform. It is benchmarking preCISION directly against Enhertu and Datroway, and the tumor selectivity numbers matter.
PCI Pharma Services bets over $1bn on US sterile fill-finish capacity as drug supply chains localize
Drugmakers want US capacity, but sterile fill-finish remains scarce. PCI Pharma Services is betting over $1B that resilience now wins contracts.
Avacta (AIM: AVCT): First patient dosed in FOCUS-01 with three data catalysts lined up across 2026
Avacta (AIM: AVCT) dosed the first FOCUS-01 patient in March 2026. Three catalysts follow: AACR April 21, AVA6000 H1 update, AVA6103 late H2 data. Full retail investor roadmap inside.
NVRI near 52-week high as Enviri clears final regulatory hurdle for $3.04bn Clean Earth sale to Veolia
Enviri (NVRI) clears HSR antitrust review for $3B Clean Earth sale to Veolia. SEC filings due this month. What happens next for NVRI investors? Read more.